We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Oncolytic therapies, drugs which trigger cancer cell death, lysis, and an immune response, have been regulatory approved for just under two decades, globally.